MiMARK
MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.
B2X
0
Country
Email Address
Founded Date
2021
Headquarters
Investors
Latest Funding Round Date
November 28, 2023
Latest Funding Round Amount (USD)
4,200,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
4,200,000
Official Website
Find more companies like MiMARK
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.